Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs

In South Africa (SA) universal access to treatment for HIV-infected individuals in need has yet to be achieved. Currently ~1 million receive treatment, but an additional 1.6 million are in need. It is being debated whether to use a universal 'test and treat' (T&T) strategy to try to el...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2012-09, Vol.7 (9), p.e41212-e41212
Hauptverfasser:	Wagner, Bradley G, Blower, Sally
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome AIDS AIDS treatment Analysis Antiretroviral drugs CD4-Positive T-Lymphocytes - cytology Communicable Disease Control Computer Science Costs Drug resistance Drug Resistance, Viral Economic aspects Epidemics Health Care Costs Health Services Accessibility Health Services Needs and Demand - economics HIV HIV Infections - diagnosis HIV Infections - economics HIV Infections - epidemiology HIV Infections - therapy Human immunodeficiency virus Humans Infectivity Mathematical models Medicine Models, Theoretical Predictions Prevalence Prevention South Africa Strategy World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!